Last 12 months
Inside the activity.
0 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 20, 2025 Filed Oct 21, 2025 20:42 UTC |
EVRAN SEDATEVP, Global Supply Chain
|
Exercise / conversionBio-Rad A Common Stock | 1,044 | $0.00 | $0.00 |
DisclosureSEC source: 0001993147-25-000006 · wk-form4_1761079318.xml · nonDerivative · entry 1 EVRAN SEDAT · CIK 0001993147 · EVP, Global Supply Chain 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,567.847 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 06, 2025 Filed Sep 9, 2025 20:23 UTC |
Lakkaraju Roop KalyanEVP, Chief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,535 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001396867-25-000004 · wk-form4_1757449415.xml · derivative · entry 4 Lakkaraju Roop Kalyan · CIK 0001396867 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,608 Underlying: Bio-Rad A Common Stock · 1,535 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F4 · derivative.exercise_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. F4 · derivative.expiration_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. Read SEC document |
| September 06, 2025 Filed Sep 9, 2025 20:23 UTC |
Lakkaraju Roop KalyanEVP, Chief Financial Officer
|
Tax withholdingBio-Rad A Common Stock | 550 | $295.43 | $162,486.50 |
DisclosureSEC source: 0001396867-25-000004 · wk-form4_1757449415.xml · nonDerivative · entry 2 Lakkaraju Roop Kalyan · CIK 0001396867 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,843.659 Read SEC document |
| September 06, 2025 Filed Sep 9, 2025 20:23 UTC |
Lakkaraju Roop KalyanEVP, Chief Financial Officer
|
Exercise / conversionBio-Rad A Common Stock | 1,535 | $0.00 | $0.00 |
DisclosureSEC source: 0001396867-25-000004 · wk-form4_1757449415.xml · nonDerivative · entry 1 Lakkaraju Roop Kalyan · CIK 0001396867 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,393.659 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. F2 · balance_after: Includes 13.2750 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 06/30/2025. Read SEC document |
| September 06, 2025 Filed Sep 9, 2025 20:24 UTC |
EVRAN SEDATEVP, Global Supply Chain
|
Exercise / conversionRestricted Stock Units · Derivative | 864 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001993147-25-000004 · wk-form4_1757449440.xml · derivative · entry 4 EVRAN SEDAT · CIK 0001993147 · EVP, Global Supply Chain 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,592 Underlying: Bio-Rad A Common Stock · 864 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F4 · derivative.exercise_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. F4 · derivative.expiration_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. Read SEC document |
| September 06, 2025 Filed Sep 9, 2025 20:24 UTC |
EVRAN SEDATEVP, Global Supply Chain
|
Tax withholdingBio-Rad A Common Stock | 277 | $295.43 | $81,834.11 |
DisclosureSEC source: 0001993147-25-000004 · wk-form4_1757449440.xml · nonDerivative · entry 2 EVRAN SEDAT · CIK 0001993147 · EVP, Global Supply Chain 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,523.847 Read SEC document |
| September 06, 2025 Filed Sep 9, 2025 20:24 UTC |
EVRAN SEDATEVP, Global Supply Chain
|
Exercise / conversionBio-Rad A Common Stock | 864 | $0.00 | $0.00 |
DisclosureSEC source: 0001993147-25-000004 · wk-form4_1757449440.xml · nonDerivative · entry 1 EVRAN SEDAT · CIK 0001993147 · EVP, Global Supply Chain 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,800.847 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. F2 · balance_after: Includes 56.9880 and 26.7190 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 03/31/2025 and 06/30/2025, respectively. Read SEC document |
| September 06, 2025 Filed Sep 9, 2025 20:23 UTC |
COREY COLLEENEVP, Global Human Resources
|
Exercise / conversionRestricted Stock Units · Derivative | 576 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001976271-25-000006 · wk-form4_1757449384.xml · derivative · entry 4 COREY COLLEEN · CIK 0001976271 · EVP, Global Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,728 Underlying: Bio-Rad A Common Stock · 576 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F3 · derivative.exercise_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. F3 · derivative.expiration_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. Read SEC document |
| September 06, 2025 Filed Sep 9, 2025 20:23 UTC |
COREY COLLEENEVP, Global Human Resources
|
Tax withholdingBio-Rad A Common Stock | 209 | $295.43 | $61,744.87 |
DisclosureSEC source: 0001976271-25-000006 · wk-form4_1757449384.xml · nonDerivative · entry 2 COREY COLLEEN · CIK 0001976271 · EVP, Global Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,550 Read SEC document |
| September 06, 2025 Filed Sep 9, 2025 20:23 UTC |
COREY COLLEENEVP, Global Human Resources
|
Exercise / conversionBio-Rad A Common Stock | 576 | $0.00 | $0.00 |
DisclosureSEC source: 0001976271-25-000006 · wk-form4_1757449384.xml · nonDerivative · entry 1 COREY COLLEEN · CIK 0001976271 · EVP, Global Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,759 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 06, 2025 Filed Sep 9, 2025 20:22 UTC |
BARRY JAMESEVP, President, LSG
|
Exercise / conversionRestricted Stock Units · Derivative | 1,056 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0002022345-25-000006 · wk-form4_1757449335.xml · derivative · entry 4 BARRY JAMES · CIK 0002022345 · EVP, President, LSG 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,168 Underlying: Bio-Rad A Common Stock · 1,056 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F3 · derivative.exercise_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. F3 · derivative.expiration_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. Read SEC document |
| September 06, 2025 Filed Sep 9, 2025 20:22 UTC |
BARRY JAMESEVP, President, LSG
|
Tax withholdingBio-Rad A Common Stock | 378 | $295.43 | $111,672.54 |
DisclosureSEC source: 0002022345-25-000006 · wk-form4_1757449335.xml · nonDerivative · entry 2 BARRY JAMES · CIK 0002022345 · EVP, President, LSG 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,209.555 Read SEC document |
| September 06, 2025 Filed Sep 9, 2025 20:22 UTC |
BARRY JAMESEVP, President, LSG
|
Exercise / conversionBio-Rad A Common Stock | 1,056 | $0.00 | $0.00 |
DisclosureSEC source: 0002022345-25-000006 · wk-form4_1757449335.xml · nonDerivative · entry 1 BARRY JAMES · CIK 0002022345 · EVP, President, LSG 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,587.555 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 06, 2025 Filed Sep 9, 2025 20:21 UTC |
Allison SchwartzDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 92 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001924980-25-000006 · wk-form4_1757449314.xml · derivative · entry 4 Allison Schwartz · CIK 0001924980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 277 Underlying: Bio-Rad A Common Stock · 92 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F3 · derivative.exercise_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. F3 · derivative.expiration_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. Read SEC document |
| September 06, 2025 Filed Sep 9, 2025 20:21 UTC |
Allison SchwartzDirector
|
Tax withholdingBio-Rad A Common Stock | 33 | $295.43 | $9,749.19 |
DisclosureSEC source: 0001924980-25-000006 · wk-form4_1757449314.xml · nonDerivative · entry 2 Allison Schwartz · CIK 0001924980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,456 Read SEC document |
| September 06, 2025 Filed Sep 9, 2025 20:21 UTC |
Allison SchwartzDirector
|
Exercise / conversionBio-Rad A Common Stock | 92 | $0.00 | $0.00 |
DisclosureSEC source: 0001924980-25-000006 · wk-form4_1757449314.xml · nonDerivative · entry 1 Allison Schwartz · CIK 0001924980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,489 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 06, 2025 Filed Sep 9, 2025 20:21 UTC |
ENGELHARDT EVA ANETTEEVP, President, CDG
|
Exercise / conversionRestricted Stock Units · Derivative | 1,152 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0002024911-25-000006 · wk-form4_1757449263.xml · derivative · entry 4 ENGELHARDT EVA ANETTE · CIK 0002024911 · EVP, President, CDG 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,456 Underlying: Bio-Rad A Common Stock · 1,152 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F3 · derivative.exercise_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. F3 · derivative.expiration_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. Read SEC document |
| September 06, 2025 Filed Sep 9, 2025 20:21 UTC |
ENGELHARDT EVA ANETTEEVP, President, CDG
|
Tax withholdingBio-Rad A Common Stock | 413 | $295.43 | $122,012.59 |
DisclosureSEC source: 0002024911-25-000006 · wk-form4_1757449263.xml · nonDerivative · entry 2 ENGELHARDT EVA ANETTE · CIK 0002024911 · EVP, President, CDG 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 896 Read SEC document |
| September 06, 2025 Filed Sep 9, 2025 20:21 UTC |
ENGELHARDT EVA ANETTEEVP, President, CDG
|
Exercise / conversionBio-Rad A Common Stock | 1,152 | $0.00 | $0.00 |
DisclosureSEC source: 0002024911-25-000006 · wk-form4_1757449263.xml · nonDerivative · entry 1 ENGELHARDT EVA ANETTE · CIK 0002024911 · EVP, President, CDG 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,309 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 06, 2025 Filed Sep 9, 2025 20:20 UTC |
ENLOE COURTNEY CEVP, General Counsel & Sec
|
Exercise / conversionRestricted Stock Units · Derivative | 768 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0002019843-25-000005 · wk-form4_1757449221.xml · derivative · entry 4 ENLOE COURTNEY C · CIK 0002019843 · EVP, General Counsel & Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,304 Underlying: Bio-Rad A Common Stock · 768 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F4 · derivative.exercise_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. F4 · derivative.expiration_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. Read SEC document |
| September 06, 2025 Filed Sep 9, 2025 20:20 UTC |
ENLOE COURTNEY CEVP, General Counsel & Sec
|
Tax withholdingBio-Rad A Common Stock | 275 | $295.43 | $81,243.25 |
DisclosureSEC source: 0002019843-25-000005 · wk-form4_1757449221.xml · nonDerivative · entry 2 ENLOE COURTNEY C · CIK 0002019843 · EVP, General Counsel & Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 628.991 Read SEC document |
| September 06, 2025 Filed Sep 9, 2025 20:20 UTC |
ENLOE COURTNEY CEVP, General Counsel & Sec
|
Exercise / conversionBio-Rad A Common Stock | 768 | $0.00 | $0.00 |
DisclosureSEC source: 0002019843-25-000005 · wk-form4_1757449221.xml · nonDerivative · entry 1 ENLOE COURTNEY C · CIK 0002019843 · EVP, General Counsel & Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 903.991 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. F2 · balance_after: Includes 6.5980 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 06/30/2025. Read SEC document |
| September 06, 2025 Filed Sep 9, 2025 20:19 UTC |
SCHWARTZ NORMAN DDirector · Chairman & CEO · 10% owner
|
Exercise / conversionRestricted Stock Units · Derivative | 3,455 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000940805-25-000006 · wk-form4_1757449196.xml · derivative · entry 7 SCHWARTZ NORMAN D · CIK 0000940805 · Director · Chairman & CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,367 Underlying: Bio-Rad A Common Stock · 3,455 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F5 · derivative.exercise_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. F5 · derivative.expiration_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. Read SEC document |
| September 06, 2025 Filed Sep 9, 2025 20:19 UTC |
SCHWARTZ NORMAN DDirector · Chairman & CEO · 10% owner
|
Tax withholdingBio-Rad A Common Stock | 1,528 | $295.43 | $451,417.04 |
DisclosureSEC source: 0000940805-25-000006 · wk-form4_1757449196.xml · nonDerivative · entry 2 SCHWARTZ NORMAN D · CIK 0000940805 · Director · Chairman & CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 443,434 Read SEC document |
| September 06, 2025 Filed Sep 9, 2025 20:19 UTC |
SCHWARTZ NORMAN DDirector · Chairman & CEO · 10% owner
|
Exercise / conversionBio-Rad A Common Stock | 3,455 | $0.00 | $0.00 |
DisclosureSEC source: 0000940805-25-000006 · wk-form4_1757449196.xml · nonDerivative · entry 1 SCHWARTZ NORMAN D · CIK 0000940805 · Director · Chairman & CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 444,962 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 05, 2025 Filed Sep 9, 2025 20:23 UTC |
Lakkaraju Roop KalyanEVP, Chief Financial Officer
|
GrantRestricted Stock Units · Derivative | 5,480 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001396867-25-000004 · wk-form4_1757449415.xml · derivative · entry 3 Lakkaraju Roop Kalyan · CIK 0001396867 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,480 Underlying: Bio-Rad A Common Stock · 5,480 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F4 · derivative.exercise_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. F4 · derivative.expiration_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. Read SEC document |
| September 05, 2025 Filed Sep 9, 2025 20:24 UTC |
EVRAN SEDATEVP, Global Supply Chain
|
GrantRestricted Stock Units · Derivative | 4,110 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001993147-25-000004 · wk-form4_1757449440.xml · derivative · entry 3 EVRAN SEDAT · CIK 0001993147 · EVP, Global Supply Chain 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,110 Underlying: Bio-Rad A Common Stock · 4,110 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F4 · derivative.exercise_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. F4 · derivative.expiration_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. Read SEC document |
| September 05, 2025 Filed Sep 9, 2025 20:23 UTC |
COREY COLLEENEVP, Global Human Resources
|
GrantRestricted Stock Units · Derivative | 2,740 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001976271-25-000006 · wk-form4_1757449384.xml · derivative · entry 3 COREY COLLEEN · CIK 0001976271 · EVP, Global Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,740 Underlying: Bio-Rad A Common Stock · 2,740 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F3 · derivative.exercise_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. F3 · derivative.expiration_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. Read SEC document |
| September 05, 2025 Filed Sep 9, 2025 20:22 UTC |
BARRY JAMESEVP, President, LSG
|
GrantRestricted Stock Units · Derivative | 4,110 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0002022345-25-000006 · wk-form4_1757449335.xml · derivative · entry 3 BARRY JAMES · CIK 0002022345 · EVP, President, LSG 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,110 Underlying: Bio-Rad A Common Stock · 4,110 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F3 · derivative.exercise_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. F3 · derivative.expiration_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. Read SEC document |
| September 05, 2025 Filed Sep 9, 2025 20:21 UTC |
Allison SchwartzDirector
|
GrantRestricted Stock Units · Derivative | 914 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001924980-25-000006 · wk-form4_1757449314.xml · derivative · entry 3 Allison Schwartz · CIK 0001924980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 914 Underlying: Bio-Rad A Common Stock · 914 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F3 · derivative.exercise_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. F3 · derivative.expiration_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. Read SEC document |
| September 05, 2025 Filed Sep 9, 2025 20:21 UTC |
ENGELHARDT EVA ANETTEEVP, President, CDG
|
GrantRestricted Stock Units · Derivative | 4,110 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0002024911-25-000006 · wk-form4_1757449263.xml · derivative · entry 3 ENGELHARDT EVA ANETTE · CIK 0002024911 · EVP, President, CDG 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,110 Underlying: Bio-Rad A Common Stock · 4,110 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F3 · derivative.exercise_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. F3 · derivative.expiration_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. Read SEC document |
| September 05, 2025 Filed Sep 9, 2025 20:21 UTC |
DiVincenzo Jonathan P.President & COO
|
GrantRestricted Stock Units · Derivative | 6,850 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001453524-25-000004 · wk-form4_1757449290.xml · derivative · entry 1 DiVincenzo Jonathan P. · CIK 0001453524 · President & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,850 Underlying: Bio-Rad A Common Stock · 6,850 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F2 · derivative.exercise_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. F2 · derivative.expiration_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. Read SEC document |
| September 05, 2025 Filed Sep 9, 2025 20:20 UTC |
ENLOE COURTNEY CEVP, General Counsel & Sec
|
GrantRestricted Stock Units · Derivative | 2,740 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0002019843-25-000005 · wk-form4_1757449221.xml · derivative · entry 3 ENLOE COURTNEY C · CIK 0002019843 · EVP, General Counsel & Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,740 Underlying: Bio-Rad A Common Stock · 2,740 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F4 · derivative.exercise_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. F4 · derivative.expiration_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. Read SEC document |
| September 05, 2025 Filed Sep 9, 2025 20:19 UTC |
SCHWARTZ NORMAN DDirector · Chairman & CEO · 10% owner
|
GrantRestricted Stock Units · Derivative | 16,439 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000940805-25-000006 · wk-form4_1757449196.xml · derivative · entry 6 SCHWARTZ NORMAN D · CIK 0000940805 · Director · Chairman & CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,439 Underlying: Bio-Rad A Common Stock · 16,439 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F5 · derivative.exercise_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. F5 · derivative.expiration_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. Read SEC document |
| September 05, 2025 Filed Sep 9, 2025 20:19 UTC |
Mehta RajatEVP, GBL Commercial Operations
|
GrantRestricted Stock Units · Derivative | 5,480 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0002081681-25-000008 · wk-form4_1757449148.xml · derivative · entry 2 Mehta Rajat · CIK 0002081681 · EVP, GBL Commercial Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,480 Underlying: Bio-Rad A Common Stock · 5,480 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F3 · derivative.exercise_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. F3 · derivative.expiration_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. Read SEC document |
| September 05, 2025 Filed Sep 9, 2025 20:19 UTC |
Mehta RajatEVP, GBL Commercial Operations
|
GrantRestricted Stock Units · Derivative | 1,827 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0002081681-25-000008 · wk-form4_1757449148.xml · derivative · entry 1 Mehta Rajat · CIK 0002081681 · EVP, GBL Commercial Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,827 Underlying: Bio-Rad A Common Stock · 1,827 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F2 · derivative.exercise_date: On September 5, 2025, the reporting person was granted 1,827 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F2 · derivative.expiration_date: On September 5, 2025, the reporting person was granted 1,827 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 01, 2025 Filed Sep 3, 2025 22:03 UTC |
Allison SchwartzDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 74 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001924980-25-000004 · wk-form4_1756937031.xml · derivative · entry 5 Allison Schwartz · CIK 0001924980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150 Underlying: Bio-Rad A Common Stock · 74 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F5 · derivative.exercise_date: On September 1, 2023, the reporting person was granted 298 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F5 · derivative.expiration_date: On September 1, 2023, the reporting person was granted 298 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 01, 2025 Filed Sep 3, 2025 22:03 UTC |
Allison SchwartzDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 42 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001924980-25-000004 · wk-form4_1756937031.xml · derivative · entry 4 Allison Schwartz · CIK 0001924980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42 Underlying: Bio-Rad A Common Stock · 42 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F4 · derivative.exercise_date: On September 1, 2022, the reporting person was granted 167 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F4 · derivative.expiration_date: On September 1, 2022, the reporting person was granted 167 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 01, 2025 Filed Sep 3, 2025 22:03 UTC |
Allison SchwartzDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 31 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001924980-25-000004 · wk-form4_1756937031.xml · derivative · entry 3 Allison Schwartz · CIK 0001924980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Bio-Rad A Common Stock · 31 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F3 · derivative.exercise_date: On September 1, 2021, the reporting person was granted 122 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F3 · derivative.expiration_date: On September 1, 2021, the reporting person was granted 122 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 01, 2025 Filed Sep 3, 2025 22:03 UTC |
Allison SchwartzDirector
|
Tax withholdingBio-Rad A Common Stock | 55 | $297.88 | $16,383.40 |
DisclosureSEC source: 0001924980-25-000004 · wk-form4_1756937031.xml · nonDerivative · entry 2 Allison Schwartz · CIK 0001924980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,397 Read SEC document |
| September 01, 2025 Filed Sep 3, 2025 22:03 UTC |
Allison SchwartzDirector
|
Exercise / conversionBio-Rad A Common Stock | 147 | $0.00 | $0.00 |
DisclosureSEC source: 0001924980-25-000004 · wk-form4_1756937031.xml · nonDerivative · entry 1 Allison Schwartz · CIK 0001924980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,452 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 01, 2025 Filed Sep 3, 2025 22:03 UTC |
BARRY JAMESEVP, President, LSG
|
Exercise / conversionRestricted Stock Units · Derivative | 250 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0002022345-25-000004 · wk-form4_1756936979.xml · derivative · entry 5 BARRY JAMES · CIK 0002022345 · EVP, President, LSG 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 502 Underlying: Bio-Rad A Common Stock · 250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F5 · derivative.exercise_date: On September 1, 2023, the reporting person was granted 1,002 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F5 · derivative.expiration_date: On September 1, 2023, the reporting person was granted 1,002 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 01, 2025 Filed Sep 3, 2025 22:03 UTC |
BARRY JAMESEVP, President, LSG
|
Exercise / conversionRestricted Stock Units · Derivative | 174 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0002022345-25-000004 · wk-form4_1756936979.xml · derivative · entry 4 BARRY JAMES · CIK 0002022345 · EVP, President, LSG 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 174 Underlying: Bio-Rad A Common Stock · 174 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F4 · derivative.exercise_date: On September 1, 2022, the reporting person was granted 694 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F4 · derivative.expiration_date: On September 1, 2022, the reporting person was granted 694 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 01, 2025 Filed Sep 3, 2025 22:03 UTC |
BARRY JAMESEVP, President, LSG
|
Exercise / conversionRestricted Stock Units · Derivative | 178 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0002022345-25-000004 · wk-form4_1756936979.xml · derivative · entry 3 BARRY JAMES · CIK 0002022345 · EVP, President, LSG 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Bio-Rad A Common Stock · 178 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F3 · derivative.exercise_date: On September 1, 2021, the reporting person was granted 709 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F3 · derivative.expiration_date: On September 1, 2021, the reporting person was granted 709 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 01, 2025 Filed Sep 3, 2025 22:03 UTC |
BARRY JAMESEVP, President, LSG
|
Tax withholdingBio-Rad A Common Stock | 217 | $297.88 | $64,639.96 |
DisclosureSEC source: 0002022345-25-000004 · wk-form4_1756936979.xml · nonDerivative · entry 2 BARRY JAMES · CIK 0002022345 · EVP, President, LSG 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 531.555 Read SEC document |
| September 01, 2025 Filed Sep 3, 2025 22:03 UTC |
BARRY JAMESEVP, President, LSG
|
Exercise / conversionBio-Rad A Common Stock | 602 | $0.00 | $0.00 |
DisclosureSEC source: 0002022345-25-000004 · wk-form4_1756936979.xml · nonDerivative · entry 1 BARRY JAMES · CIK 0002022345 · EVP, President, LSG 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 748.555 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 01, 2025 Filed Sep 3, 2025 22:02 UTC |
COREY COLLEENEVP, Global Human Resources
|
Exercise / conversionRestricted Stock Units · Derivative | 501 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001976271-25-000004 · wk-form4_1756936927.xml · derivative · entry 5 COREY COLLEEN · CIK 0001976271 · EVP, Global Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,002 Underlying: Bio-Rad A Common Stock · 501 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F5 · derivative.exercise_date: On September 1, 2023, the reporting person was granted 2,003 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F5 · derivative.expiration_date: On September 1, 2023, the reporting person was granted 2,003 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 01, 2025 Filed Sep 3, 2025 22:02 UTC |
COREY COLLEENEVP, Global Human Resources
|
Exercise / conversionRestricted Stock Units · Derivative | 347 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001976271-25-000004 · wk-form4_1756936927.xml · derivative · entry 4 COREY COLLEEN · CIK 0001976271 · EVP, Global Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 347 Underlying: Bio-Rad A Common Stock · 347 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F4 · derivative.exercise_date: On September 1, 2022, the reporting person was granted 1,388 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F4 · derivative.expiration_date: On September 1, 2022, the reporting person was granted 1,388 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 01, 2025 Filed Sep 3, 2025 22:02 UTC |
COREY COLLEENEVP, Global Human Resources
|
Exercise / conversionRestricted Stock Units · Derivative | 254 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001976271-25-000004 · wk-form4_1756936927.xml · derivative · entry 3 COREY COLLEEN · CIK 0001976271 · EVP, Global Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Bio-Rad A Common Stock · 254 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F3 · derivative.exercise_date: On September 1, 2021, the reporting person was granted 1,013 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F3 · derivative.expiration_date: On September 1, 2021, the reporting person was granted 1,013 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 01, 2025 Filed Sep 3, 2025 22:02 UTC |
COREY COLLEENEVP, Global Human Resources
|
Tax withholdingBio-Rad A Common Stock | 398 | $297.88 | $118,556.24 |
DisclosureSEC source: 0001976271-25-000004 · wk-form4_1756936927.xml · nonDerivative · entry 2 COREY COLLEEN · CIK 0001976271 · EVP, Global Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,183 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.